Viktor Vass
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 4
- Hormonal Regulation and Hypertension 1
- Diabetes Management and Research 1
-
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Zoltán Balogh (1 shared paper)Péter Stella (1 shared paper)Tibor Hídvégi (1 shared paper)
- Partner nations
- Hungary
In The Last Decade
Viktor Vass
5 papers receiving 4.2k citations
Viktor Vass's Hit Papers
Peers
Comparison fields: 5 of 79
- Endocrinology, Diabetes and Metabolism 3.3k
- Nephrology 577
- Cardiology and Cardiovascular Medicine 483
- Pharmacology 113
- Transplantation 24
Countries citing papers authored by Viktor Vass
This map shows the geographic impact of Viktor Vass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Vass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Vass more than expected).
Fields of papers citing papers by Viktor Vass
This network shows the impact of papers produced by Viktor Vass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Vass. The network helps show where Viktor Vass may publish in the future.
Co-authors
The 3 scholars most cited alongside Viktor Vass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1445 |
| 3 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 4 | Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Hit paper breakdown → | 2023 | 149 |
| 5 | 2020 | 3 |
About Viktor Vass
Viktor Vass is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 5 papers that have together received 4.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Chronic Kidney Disease and Diabetes (2 papers), Hormonal Regulation and Hypertension (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Nephrology (577 citations), Cardiology and Cardiovascular Medicine (483 citations), Pharmacology (113 citations) and Transplantation (24 citations). Viktor Vass has collaborated with scholars based in Hungary. Frequent co-authors include Zoltán Balogh, Péter Stella and Tibor Hídvégi. Their work appears in journals such as The Lancet and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.